Biotech entity
clinical-trial is the sole category represented across all 1 tracked stories. Boots is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 3 original sources each. Superdrug appears in 1 tracked Biotech story from June 15, 2026.
Last mentioned: Jun 15, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
clinical-trial is the sole category represented across all 1 tracked stories. Boots is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 3 original sources each. Superdrug appears in 1 tracked Biotech story from June 15, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Superdrug. Shared-story counts are live from our verified record — not editorial picks.
First Patient Fulfillment Expected
Private providers anticipate delivering the first courses of the oral medication to patients by early July 2026, though the exact date may vary.
MHRA Approves Oral Wegovy
The UK's Medicines and Healthcare Products Regulatory Agency licenses the daily semaglutide pill for private prescription, setting eligibility criteria based on BMI.
Private Pharmacies Begin Taking Orders
Boots, Superdrug, Morrisons and other licensed retailers start selling the Wegovy Pill on the same day as approval, with demand pushing waiting lists towards 100,000.
Novo Nordisk's oral Wegovy achieved 16.6% mean weight loss at 64 weeks in the Phase III OASIS-4 trial, with 87% of participants losing ≥5% and one-third losing ≥20%. The once-daily pill uses a SNAC absorption enhancer, triggering MHRA approval and a new phase in the GLP-1 obesity drug race.
Source: dailymail.com · tivysideadvertiser.co.uk
Superdrug is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
